CASI Pharmaceuticals Reports 2016 Fourth Quarter And Full Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St futures rebound as oil retreats, investors weigh US-Iran tensions
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Oil prices fall as markets weigh impact of US strikes on Iran
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
CASI Pharma (CASI) Reports Q4 Loss of $0.05/Share
March 31, 2017 7:07 AM EDTCASI Pharma (NASDAQ: CASI) reported Q4 EPS of ($0.05), versus ($0.05) reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
... More